A key challenge in life sciences is the detrimental effect of unplanned downtime and lost batches due to unanticipated equipment failure. Obtaining maximum value from assets makes a lot of sense to an asset-intensive organization, and the Pharmaceutical Industry is not the exception.
19-21 March 2023